Cryotherapy reduces accommodation

Article

Eyes treated with peripheral retinal cryotherapy lose accommodative amplitude after surgery, according to results of a study published in the January 2009 issue of the American Journal of Ophthalmology.

Eyes treated with peripheral retinal cryotherapy lose accommodative amplitude after surgery, according to results of a study published in the January 2009 issue of the American Journal of Ophthalmology.

Tsuyoshi Uno of Ideta Eye Hospital, Kumamoto, Japan and colleagues examined eyes with retinal lattice degeneration (n=96) treated with cryotherapy between December 2001 and September 2004, and measured pre- and postoperative accommodative amplitudes.

Overall, researchers did not note any significant differences between pre- and postoperative accommodative amplitudes, although patients aged 10–29 years demonstrated decreased accommodative amplitudes when measured one and three weeks after treatment. Within this age bracket, this decrease was more significant in younger subjects, although, for all patients, accommodative amplitude returned to pretreatment levels by week six. The researchers also noted an association between acute loss of accommodation and cryotherapy numbers.

The researchers concluded that, although short-term losses in accommodation are possible, and more common in patients aged 10–29 years, these losses resolved within six weeks.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.